Acta Pharmaceutica Sinica. B

The Journal of the Institute of Materia Medica, Chinese Academy of Medical Sciences, and the Chinese Pharmaceutical Association oversees the peer review process for Acta Pharmaceutica Sinica. B (APSB). Published monthly in English, APSB is dedicated to disseminating significant original research articles, rapid communications, and high-quality reviews that highlight recent advances across various pharmaceutical sciences domains. These encompass pharmacology, pharmaceutics, medicinal chemistry, natural products, pharmacognosy, pharmaceutical analysis, and pharmacokinetics. A part of the Acta Pharmaceutica Sinica series, established in 1953 and indexed in prominent databases like Chemical Abstracts, Index Medicus, SciFinder Scholar, Biological Abstracts, International Pharmaceutical Abstracts, Cambridge Scientific Abstracts, and Current Bibliography on Science and Technology, APSB is sponsored by the Institute of Materia Medica, Chinese Academy of Medical Sciences, and the Chinese Pharmaceutical Association. Its production and hosting are facilitated by Elsevier B.V. This collaborative effort ensures APSB's commitment to delivering valuable contributions to the pharmaceutical sciences community.

《Acta Pharmaceutica Sinica. B》（APSB）的同行评审过程由中国医学科学院药物研究所学报和中国药学会监督。它有Elsevier BV出版，中科院SCI期刊分区为大类医学1区。APSB 每月以英文出版，致力于传播重要的原创研究文章、快速沟通和高质量评论，突出各个制药科学领域的最新进展。 这些包括药理学、药剂学、药物化学、天然产物、生药学、药物分析和药代动力学。APSB 是《药学报》丛书的一部分，该丛书成立于 1953 年，并被化学文摘、Index Medicus、SciFinder Scholar、Biological Abstracts、International Pharmaceutical Abstracts、Cambridge Scientific Abstracts 和 Current Bibliography on Science and Technology 等著名数据库索引。它由中国医学科学院药物研究所、中国药学会主办。